Actively Recruiting

Age: 18Years +
All Genders
NCT05448703

A Study on Predictive Models and Clinical Outcome of Radiation Pneumonitis

Led by Huazhong University of Science and Technology · Updated on 2022-10-06

300

Participants Needed

3

Research Sites

287 weeks

Total Duration

On this page

Sponsors

H

Huazhong University of Science and Technology

Lead Sponsor

H

Hubei Cancer Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

Radiation pneumonitis is the main dose-limiting toxicity of thoracic radiotherapy, which can affect life quality, survival, and the tumor-controlling effects of patients receiving thoracic radiotherapy. The purpose of this study is to: * Identify biomarkers including serum proteins, gene expression, genetic changes, and epigenetic modifications that determine radiation pneumonitis. * Investigate the relationship between radiation pneumonitis and other toxicities induced by radiotherapy. * Construct a predictive model for radiation pneumonitis. * Evaluate survival and treatment outcome of patients with radiation pneumonitis.

CONDITIONS

Official Title

A Study on Predictive Models and Clinical Outcome of Radiation Pneumonitis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Clinical diagnosis of lung cancer by histology
  • Radiation dose at least 45 Gy
  • Karnofsky score greater than 60
  • Age above 18 years
  • Life expectancy of at least 6 months
Not Eligible

You will not qualify if you...

  • Previous thoracic irradiation
  • Severe cardiopulmonary diseases

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, China, 43000

Actively Recruiting

2

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, China, 430030

Actively Recruiting

3

Jingjiang People' Hospital

Jingjiang, Jiangsu, China, 214500

Actively Recruiting

Loading map...

Research Team

X

Xianglin Yuan, PhD

CONTACT

L

Lingyan Xiao, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here